Addus HomeCare Corporation (ADUS) vs Immunome, Inc. (IMNM)

A side-by-side comparison of Addus HomeCare Corporation and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Addus HomeCare Corporation logo
ADUS
Addus HomeCare Corporation
$2.12B
$113.53HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Immunome, Inc. logo
IMNM
Immunome, Inc.
$1.95B
$20.37HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

Total return — ADUS vs IMNM

growth of $100 · dividends reinvested · last 6y
ADUS +15.7% (+2.5%/yr)IMNM +57.4% (+7.9%/yr)IMNM compounded faster over this window
0100200300Start $100202120222023202420252026$116$157
ADUS IMNM

ADUS vs IMNM: by the numbers

  • •ADUS is the larger company ($2.12B vs $1.95B market cap).
  • •ADUS is profitable (7.13% net margin) while IMNM runs a net loss (-3059.99%).

Metrics side by side

Valuation

MetricADUSIMNM
P/E ratio19.92N/A
Forward P/E16.11N/A
PEG ratio0.99N/A
P/S ratio1.44N/A
P/B ratio1.853.71
EV / EBITDA12.90N/A
FCF yield7.22%N/A

Profitability

MetricADUSIMNM
Gross margin32.36%57.43%
Operating margin10.04%-3084.76%
Net margin7.13%-3059.99%
ROE9.17%-48.43%
ROIC8.61%-51.06%

Growth (annualized)

MetricADUSIMNM
Revenue CAGR (5Y)12.67%N/A
EPS CAGR (5Y)19.61%N/A
FCF CAGR (5Y)24.41%N/A
Total return CAGR (5Y)8.33%2.88%

Frequently asked

Is ADUS or IMNM more profitable?
ADUS runs the higher net margin — ADUS at 7.13% versus IMNM at -3059.99%.
How have ADUS and IMNM total returns compared?
Over the past 5 years, ADUS delivered 8.33% and IMNM delivered 2.88% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADUS analysisFull IMNM analysisInteractive comparison tool

Dig into the metrics

Addus HomeCare P/E ratioAddus HomeCare ROEImmunome ROEAddus HomeCare operating marginImmunome operating marginAddus HomeCare revenue growthImmunome revenue growthAddus HomeCare free cash flowImmunome free cash flow

Addus HomeCare & Immunome appear in these rankings

Highest FCF Yield StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.